Cost-effectiveness Comparison of Monovalent C Versus Quadrivalent ACWY Meningococcal Conjugate Vaccination in Canada-Reference-Cited by-同舟云学术

Cost-effectiveness Comparison of Monovalent C Versus Quadrivalent ACWY Meningococcal Conjugate Vaccination in Canada

Published:2017-07 Issue:7 Volume:36 Page:e203-e207
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

De Wals Philippe,Zhou Zhou

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology, and Child Health

Reference26 articles.

1. Cost-effectiveness of immunization strategies for the control of serogroup C meningococcal disease.;De Wals;Vaccine,2004

2. Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis.;De Wals;Vaccine,2007

3. WHO Guide for standardisation of economic evaluations of immunization programmes.;Walker;Vaccine,2010

4. What would be the best schedule for prevention of meningococcal disease in all ages? The UK experience.;Findlow;Paediatr Drugs,2016

5. An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS).;Can Commun Dis Rep,2009

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella;PharmacoEconomics;2023-02-21

2. Cost-effectiveness of meningococcal vaccination of Norwegian teenagers with a quadrivalent ACWY conjugate vaccine;Human Vaccines & Immunotherapeutics;2021-02-25

3. Use of Cost-Effectiveness Analyses for Decisions About Vaccination Programs for Meningococcal Disease in the United States, United Kingdom, The Netherlands, and Canada;Expert Review of Vaccines;2021-01-02

4. Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT)vs. a licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine in meningococcal vaccine-naïve and meningococcal C conjugate vaccine-primed toddlers: a phase III randomised study;Epidemiology and Infection;2021

5. Evaluating Vaccination Programs That Prevent Diseases With Potentially Catastrophic Health Outcomes: How Can We Capture the Value of Risk Reduction?;Value in Health;2021-01